Literature DB >> 8518268

Personal audit in orthodontics.

S Richmond1.   

Abstract

The use of different criteria to assess outcome of orthodontic treatment makes it difficult to compare treatment from one individual practitioner to the next. This article describes a method for all dentists to use to record outcome for self-audit purposes. A sample of 51 consecutively treated patients was assessed. On average, the mean percentage reduction in PAR score was 74 per cent. Eight per cent of patients were categorized as 'Worse or no different', 39 per cent 'Improved' and 53 per cent 'Greatly improved'. To achieve a good standard of orthodontic treatment it is proposed that the mean percentage reduction in PAR score should be greater than 70 per cent. The proportion of patients falling into the 'Worse or no different' category should ideally be less than 5 per cent.

Entities:  

Mesh:

Year:  1993        PMID: 8518268     DOI: 10.1179/bjo.20.2.135

Source DB:  PubMed          Journal:  Br J Orthod        ISSN: 0301-228X


  4 in total

1.  Retrospective evaluation of the outcome of orthodontic treatment in adults.

Authors:  T Riedmann; R Berg
Journal:  J Orofac Orthop       Date:  1999       Impact factor: 1.938

2.  [The course and results of the orthodontic treatment of 44 consecutively treated Class-II cases].

Authors:  A Eisel; C Katsaros; R Berg
Journal:  Fortschr Kieferorthop       Date:  1994-02

3.  The impact of the loss of first permanent molars on the duration of treatment in patients treated with orthodontic space closure and without skeletal anchorage.

Authors:  Paula Coutinho Cardoso; Paulo Mecenas; David Normando
Journal:  Prog Orthod       Date:  2022-09-12       Impact factor: 3.247

4.  Retrospective analysis of orthodontic treatment outcomes and its relation to postretention stability.

Authors:  Karina Maria Salvatore de Freitas; Marcos Roberto de Freitas; Guilherme Janson; Arnaldo Pinzan; José Fernando Castanha Henriques
Journal:  J Appl Oral Sci       Date:  2006-10       Impact factor: 2.698

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.